HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eleonora Virgilio Selected Research

Dronabinol (THC)

10/2020Cannabinoids in multiple sclerosis: A neurophysiological analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eleonora Virgilio Research Topics

Disease

7Multiple Sclerosis
01/2024 - 04/2019
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 11/2021
2Cognitive Dysfunction
08/2023 - 11/2021
2Nervous System Diseases (Neurological Disorders)
08/2023 - 06/2021
2COVID-19
12/2022 - 08/2022
2Alzheimer Disease (Alzheimer's Disease)
03/2022 - 06/2021
2Pain (Aches)
01/2021 - 10/2020
1Inflammation (Inflammations)
01/2024
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2023
1Central Nervous System Vasculitis
06/2022
1Retinal Artery Occlusion
06/2022
1Tauopathies
03/2022
1Parkinsonian Disorders (Parkinsonism)
03/2022
1Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2021
1Chronic Pain
01/2021
1Chronic Progressive Multiple Sclerosis
10/2020

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
01/2024 - 11/2021
2Vitamin DFDA LinkGeneric
08/2023 - 11/2021
2CannabinoidsIBA
01/2021 - 10/2020
1Proteins (Proteins, Gene)FDA Link
01/2024
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2024
1Messenger RNA (mRNA)IBA
12/2022
1COVID-19 VaccinesIBA
08/2022
1Fluorescein (Funduscein)FDA LinkGeneric
06/2022
1SteroidsIBA
06/2022
1DNA-Binding Proteins (DNA Binding Protein)IBA
03/2022
1tau Proteins (tau Protein)IBA
03/2022
1Amyloid beta-PeptidesIBA
11/2021
1OsteopontinIBA
06/2021
1Dronabinol (THC)FDA LinkGeneric
10/2020
1Oligoclonal BandsIBA
04/2019
1Immunoglobulin G (IgG)IBA
04/2019